07:00 , Apr 21, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4)

Musculoskeletal disease INDICATION: Osteoporosis Mouse studies suggest the extracellular binding domain of LGR4 could help treat osteoporosis. In three mouse models of osteoporosis, the LGR4 extracellular domain decreased osteoclast activity and increased bone mineral density...